Tenaya reports positive interim results for gene therapy trial

May 15, 2026 6:01 AM

Tenaya Therapeutics (NASDAQ: TNYA) reported interim data from its RIDGE-1 Phase 1b/2 clinical trial of TN-401 gene therapy for adults ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found